Chemistry: analytical and immunological testing – Composition for standardization – calibration – simulation,... – Blood gas standard or control
Patent
1991-09-27
1994-06-14
Bhat, N. a
Chemistry: analytical and immunological testing
Composition for standardization, calibration, simulation,...
Blood gas standard or control
436 15, 436 16, 436 18, 2524081, G01N 3372, G01N 3396, G01N 3300
Patent
active
053209656
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
In practice, the use of analytical equipment for measuring various parameters of blood requires utilization of control solutions which exhibit properties as close as possible to those observed in fresh normal human blood. By measuring known parameters of control solutions, the instrumentation can be monitored and calibrated to allow highly accurate measurements of patient blood samples.
One approach to monitoring the reliability and accuracy of instruments that measure partial pressures of CO.sub.2 and O.sub.2 in blood is with the use of samples of fresh human blood which has been tonometered with gas mixtures having known amounts of CO.sub.2, O.sub.2 and N.sub.2. Such a process is described by Burnett in Clinical Chemistry, 27(10):1761 (1981).
When the blood has been properly tonometered, the sample will have precise and fixed partial pressures of CO.sub.2 and O.sub.2. These prepared samples can then be introduced into the analytical instrument and pCO.sub.2 and pO.sub.2 values determined. Since the sample is similar to a patient blood specimen, but with known pCO.sub.2 and pO.sub.2 values, the instrument can be considered reliable for measuring unknown patient samples if the test values of the tonometered blood equal the theoretical values based on the gas mixture used for tonometry.
Although the use of tonometered blood is considered to be satisfactory for monitoring blood gas instrumentation, the approach has a number of drawbacks which limit its use in all but a very small percentage of laboratories.
For example, blood samples derived from human sources are susceptible to infectious agents, including hepatitis virus and HIV which can pose serious health hazards to laboratory personnel who must perform the tonometry and testing of the sample. In addition, the instruments commonly used to measure pCO.sub.2 and pO.sub.2 also measure blood pH. Since the tonometered blood does not have a known pH value, the sample cannot be used for monitoring the pH measurements and a separate pH control standard must be used.
Similarly, many laboratories that perform measurements of pCO.sub.2, pO.sub.2 and pH on blood samples also measure total hemoglobin and hemoglobin fractions on a CO-Oximeter that is located near the blood gas instrument. However, since the blood used for tonometry is acquired from random patient samples, the tonometered sample has no known hemoglobin value, and therefore it is not useful for monitoring the CO-Oximeter. Consequently, a separate control standard is required for this instrument also.
Finally, the entire procedure for properly preparing tonometered blood samples requires disciplined techniques and many laboratories lack trained personnel as well as the time to prepare the samples.
Because of these disadvantages, most laboratories use control standards which mimic human blood but have properties quite different than fresh blood. For example, buffered aqueous solutions which have been tonometered with CO.sub.2 and O.sub.2 are often used. These materials are assayed for predetermined values for pH, pCO.sub.2 and pO.sub.2. However, in composition, physical properties and chemical properties they differ greatly from whole blood.
Other control standards comprise buffered suspensions of modified human red blood cells or hemoglobin solutions prepared from lysed red blood cells. These materials have some properties which more closely approximate actual blood than do the aqueous based controls, but their pO.sub.2 buffering action and inability to provide the O.sub.2 saturation characteristics of fresh blood, cause these materials to perform more like aqueous solutions than tonometered fresh blood. Furthermore, since they are prepared from human blood, the health risk to technicians is not eliminated.
In summary, the commercial blood gas controls which are used instead of tonometered fresh human blood are generally considered a compromise between convenience, economy and the ideal control standard.
A need exists for a reference solution which is not susceptible to infe
REFERENCES:
patent: 3973913 (1976-08-01), Louderback
patent: 4163734 (1979-08-01), Sorensen et al.
patent: 4189401 (1980-02-01), Louderback
patent: 4199471 (1980-04-01), Louderback et al.
patent: 4279775 (1981-07-01), Louderback et al.
patent: 4289648 (1981-09-01), Hoskins et al.
patent: 4299728 (1981-11-01), Cormier et al.
patent: 4301117 (1981-11-01), Smernoff
patent: 4401652 (1983-08-01), Simmonds et al.
patent: 4469792 (1984-09-01), Simmonds et al.
patent: 4485174 (1984-11-01), Chiang et al.
patent: 4711852 (1987-12-01), Jacobson
patent: 4753888 (1988-06-01), Chiang
patent: 4843013 (1989-06-01), Chiang
patent: 5045529 (1991-09-01), Chiang
Sprokholt, R. and Maas, A. H. J. Physiology and Methodology of Blood Gasses and pH, vol. 4: IFCC Workshop Oslo, 67-97 (1984).
Mansouri, A., Hemoglobin, 5(6): 579-589 (1981).
Masukawa, T. and Iwata, H., Life Science, 21: 695-700 (1977).
Chanutin, A. and Curnish, R., Archives of Biochemistry and Biophysics, 121: 96-102 (1967).
Benesch, R. and Benesch, R. E., Nature, 221: 618-622 (1969).
Bhat N. a
Bionostics, Inc.
LandOfFree
Stable hemoglobin reference solution does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable hemoglobin reference solution, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable hemoglobin reference solution will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1248743